LIGHT Stock Analysis: Signify | AS
Electrical Equipment & Parts | AS, Netherlands | Market Cap: 1.944m EUR | 12M Return: -21.6% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 13.1M
EPS Trend: -16.5%
Qual. Beats: 1
Rev. Trend: -97.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.1 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Signify N.V. (LIGHT), headquartered in Eindhoven, the Netherlands, is a global lighting company that designs, manufactures, and sells lighting products, systems, and services across Europe, the Americas, and other international markets. It operates through four segments: Professional, Consumer, OEM, and Conventional. Its portfolio spans LED luminaires, LED and conventional lamps and tubes, and lighting components such as drivers, electronics, modules, and sensors, alongside legacy technologies including high-intensity discharge, compact fluorescent, halogen, incandescent, and specialty products (e.g., projection lighting). Founded in 1891, Signify serves customers ranging from consumers and electrical installers to distributors and professional end-users across offices, commercial buildings, retail, hospitality, industry, agriculture, and outdoor environments.
The company sits within the GICS Industrials sector, specifically the Electrical Components & Equipment sub-industry, and is the operating successor to Royal Philips lighting division, which was separated and listed as an independent public company in 2016. Its business model reflects the broader industry transition from conventional lighting to LED and connected (IoT-enabled) lighting systems, where value increasingly shifts from hardware to software, controls, and services such as managed lighting contracts and data-driven applications.
- Connected lighting and LED conversion drive Professional segment growth
- EUR strength pressures reported revenue and margin expansion
- Conventional segment declines as halogen and fluorescent phase-outs accelerate
| Net Income: 193.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 1.24 > 1.0 |
| NWC/Revenue: 6.47% < 20% (prev 9.47%; Δ -3.00% < -1%) |
| CFO/TA 0.08 > 3% & CFO 540.0m > Net Income 193.0m |
| Net Debt (1.16b) to EBITDA (611.0m): 1.89 < 3 |
| Current Ratio: 1.16 > 1.5 & < 3 |
| Outstanding Shares: last quarter (118.9m) vs 12m ago -4.92% < -2% |
| Gross Margin: 39.85% > 18% (prev 40.13%; Δ -0.28% > 0.5%) |
| Asset Turnover: 79.79% > 50% (prev 84.50%; Δ -4.71% > 0%) |
| Interest Coverage Ratio: 4.65 > 6 (EBIT TTM 367.0m / Interest Expense TTM 79.0m) |
| A: 0.05 (Total Current Assets 2.60b - Total Current Liabilities 2.24b) / Total Assets 6.77b |
| B: 0.14 (Retained Earnings 914.0m / Total Assets 6.77b) |
| C: 0.05 (EBIT TTM 367.0m / Avg Total Assets 7.01b) |
| D: 0.68 (Book Value of Equity 2.73b / Total Liabilities 4.00b) |
| Altman-Z'' = 1.86 = BBB |
| DSRI: 0.94 (Receivables 877.0m/1.02b, Revenue 5.59b/6.12b) |
| GMI: 1.01 (GM 40.13% / 39.85%) |
| AQI: 1.01 (AQ_t 0.53 / AQ_t-1 0.53) |
| SGI: 0.91 (Revenue 5.59b / 6.12b) |
| TATA: -0.05 (NI 193.0m - CFO 540.0m) / TA 6.77b) |
| Beneish M = -3.13 (Cap -4..+1) = AA |
As of July 07, 2026, the stock is trading at EUR 16.41 with a total of 383,185 shares traded. Over the past week, the price has changed by +0.12%, over one month by -20.03%, over three months by -4.78% and over the past year by -21.57%.
Current recommended Stop Loss: 15.50 (which is 5.5% or 1.4 ATR below the current price).
Signify has no consensus analysts rating.
P/E Trailing = 10.6234
P/E Forward = 5.9067
P/S = 0.3477
P/B = 0.711
Revenue TTM = 5.59b EUR
EBIT TTM = 367.0m EUR
EBITDA TTM = 611.0m EUR
Long Term Debt = 923.0m EUR (from longTermDebt, last fiscal year)
Short Term Debt = 485.0m EUR (from shortTermDebt, last quarter)
Debt = 1.81b EUR (from shortLongTermDebtTotal, last quarter) + Leases 227.0m
Net Debt = 1.16b EUR (calculated: Debt 1.81b - CCE 652.0m)
Enterprise Value = 3.10b EUR (1.94b + Debt 1.81b - CCE 652.0m)
Interest Coverage Ratio = 4.65 (Ebit TTM 367.0m / Interest Expense TTM 79.0m)
EV/FCF = 7.42x (Enterprise Value 3.10b / FCF TTM 418.0m)
FCF Yield = 13.48% (FCF TTM 418.0m / Enterprise Value 3.10b)
FCF Margin = 7.48% (FCF TTM 418.0m / Revenue TTM 5.59b)
Net Margin = 3.45% (Net Income TTM 193.0m / Revenue TTM 5.59b)
Gross Margin = 39.85% ((Revenue TTM 5.59b - Cost of Revenue TTM 3.36b) / Revenue TTM)
Gross Margin QoQ = 39.56% (prev 40.35%)
Tobins Q-Ratio = 0.46 (Enterprise Value 3.10b / Total Assets 6.77b)
Interest Expense / Debt = 4.37% (Interest Expense 79.0m / Debt 1.81b)
Taxrate = 21.48% (55.0m / 256.0m)
NOPAT = 288.2m (EBIT 367.0m * (1 - 21.48%))
Current Ratio = 1.16 (Total Current Assets 2.60b / Total Current Liabilities 2.24b)
Debt / Equity = 0.66 (Debt 1.81b / totalStockholderEquity, last quarter 2.73b)
Debt / EBITDA = 1.89 (Net Debt 1.16b / EBITDA 611.0m)
Debt / FCF = 2.77 (Net Debt 1.16b / FCF TTM 418.0m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.75% (Net Income 193.0m / Total Assets 6.77b)
RoE = 7.25% (Net Income TTM 193.0m / Total Stockholder Equity 2.66b)
RoCE = 10.24% (EBIT 367.0m / Capital Employed (Equity 2.66b + L.T.Debt 923.0m))
RoIC = 6.09% (NOPAT 288.2m / Invested Capital 4.73b)
WACC = 5.69% (E(1.94b)/V(3.75b) * Re(7.80%) + D(1.81b)/V(3.75b) * Rd(4.37%) * (1-Tc(0.21)))
Discount Rate = 7.80% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.93 | Cagr: -2.98%
[DCF] Terminal Value 77.97% ; FCFF base≈394.0m ; Y1≈451.7m ; Y5≈664.7m
[DCF] Fair Price = 74.45 (EV 10.0b - Net Debt 1.16b = Equity 8.85b / Shares 118.8m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -16.51 | EPS CAGR: -1.39% | SUE: 1.35 | # QB: 1
Revenue Correlation: -97.86 | Revenue CAGR: -7.80% | SUE: -0.65 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.39 | Chg30d=+55.65% | Revisions=+25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.71 | Chg30d=+23.98% | Revisions=+25% | Analysts=1
EPS current Year (2026-12-31): EPS=1.81 | Chg30d=+5.43% | Revisions=+22% | GrowthEPS=-21.4% | GrowthRev=-4.9%
EPS next Year (2027-12-31): EPS=1.99 | Chg30d=-5.76% | Revisions=-40% | GrowthEPS=+9.8% | GrowthRev=+0.1%
[Analyst] Revisions Ratio: +15% (up=6, down=4)